Michael Fath, Phd Email & Phone Number
Who is Michael Fath, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Michael Fath, Phd is listed as Medical Science Liaison at CSL, a with 23400 employees, based in Chapel Hill, North Carolina, United States. AeroLeads shows a matched LinkedIn profile for Michael Fath, Phd.
Michael Fath, Phd previously worked as Head, Global Pathogen Safety Scientific Affairs at Csl and Founder and President at Cavabio Consulting Llc. Michael Fath, Phd holds Doctor Of Philosophy - Phd, Microbiology And Molecular Genetics from Harvard University.
Email format at CSL
This section adds company-level context without repeating Michael Fath, Phd's masked contact details.
Review company-level records connected to Michael Fath, Phd before choosing the right outreach path.
About Michael Fath, Phd
I am a biopharmaceutical industry executive with a passion for unlocking the full business potential through medical affairs, global strategic marketing, and new product planning.I have been the driving force behind pre-launch and in-market initiatives for multiple products in the rare disease, plasma therapeutics, and infectious disease therapeutic areas. My track record speaks to my ability to drive biopharma pipeline success, launch innovative products, and manage brands effectively, ensuring sustained market growth.My expertise includes: * Medical Affairs * Medical Science Liaison Leadership *
Michael Fath, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
Michael Fath, Phd work experience
A career timeline built from the work history available for this profile.
Head, Global Pathogen Safety Scientific Affairs
CurrentStrategic leader and influencer on Global Pathogen Safety (GPS) Leadership team responsible to jointly define, drive, and deliver overall GPS strategy.Lead Scientific Advocate for Global Pathogen Safety at CSL in charge of growing pathogen safety awareness internally and driving external advocacy strategy.
Founder And President
Currentwww.cavabio.com | I provide strategic insights and tactical counsel in marketing, life cycle management, product development and launch, medical affairs, KOL engagement, and portfolio/asset valuation. * Recognized as a trusted advisor for biopharma, CROs, biotech start-ups, and equity investors.* Attained online certification in generative AI, leveraging these cutting-edge tools to enhance and expedite marketing strategy and tactics.
Strategy Consultant
CurrentConsultant within the MedSurgPI (www.medsurgpi.com) network, a specialized consultancy offering product development and medical affairs consulting focusing on the expansion of MedSurgPI's strategic services.
Senior Director, Product Management
Spearheaded strategic initiatives for new product development, product launches, and sales training within the leading pre-IPO life sciences metabolomics service provider. Conducted comprehensive market research, including customer interviews, to identify unmet needs and establish the target product profile. Collaborated with R&D and regulatory teams to drive all product development projects. Developed commercial forecast models for all products in development, defined pricing through market research, and spearheaded risk assessment and mitigation for commercial risks. Worked closely with sales to develop and lead sales training for all new products.* Orchestrated the successful launch of five innovative metabolomics commercial panels addressing pivotal research domains such as diabetes, inflammation, lipidomics, and cannabinoids.* Implemented a comprehensive voice of the customer market research process, established target product profiles, outlined product requirements, and developed accurate forecasts.
Senior Director, Global Marketing Bioscience
Senior Director at plasma protein therapeutics manufacturer Talecris Biotherapeutics (acquired by Grifols in 2011). Directed global marketing efforts spanning diverse brands and therapeutic areas. Delivered comprehensive annual plans encompassing global strategic plans, long-range plans, budgets, branding guidelines, global franchise workshops, congress management, market research, and KOL engagement.* Steered launch and commercial initiatives for fostamatinib (Tavlesse®), Grifols' inaugural oral therapy for chronic ITP; assisted in the due diligence process and subsequent commercialization efforts following the in-licensing from Rigel Pharmaceuticals for European and other markets; served as global launch leader and commercial lead for the joint steering committee.* Directed global marketing for Immunoglobulins – Gamunex-C® (IVIG) and newly launched Xembify® (20% SCIG), achieving annual sales over $2.0B; formulated life cycle management plans, introducing new indications like myasthenia gravis.* Orchestrated pulmonology life cycle management for Alpha-1 Antitrypsin – Prolastin-C®, launching liquid formulation and initiating aerosol clinical program for cystic fibrosis.* Guided global launch and commercial strategy for Dual Release Ciprofloxacin – Linhaliq®, a groundbreaking solution for non-cystic fibrosis bronchiectasis.* Acted as launch lead for AlphaKit QuickScreen, a companion diagnostic point-of-care screen for alpha1-antitrypsin deficiency.* Spearheaded commercial strategy for Infectious Diseases expansion, covering rabies, HBV, RSV, influenza, Zika, CDif, Gram-negative infections, and other high-acuity infectious diseases.* Steered due diligence efforts as a commercial lead, conducting market assessments, financial analyses, and business cases for new products and indications like NMOSD, PPS, and recombinant rabies hyperimmune.
Senior Vice President, Scientific Affairs
During this tenure, I led a high-performing team of Scientific Directors responsible for providing full-service scientific expertise, medical writing, and client support.
Marketing And Medical Affairs (Multiple Roles)
* Marketing Director, Virology. Led US marketing organization for HIV protease inhibitors Kaletra and Norvir. Managed team of 15 with full scope of responsibilities including professional promotion, consumer promotion, medical marketing, channel marketing, and managed care. * Director, Clinical Science, Virology. Led US Medical Affairs team of 25 MSLs to educate clinicians, drive thought-leader relationships, and manage investigator-initiated studies. Executed Long Range Planning and Clinical Portfolio programs including financial modeling, forecasting, and NPV analyses. Directed over 100 investigator-initiated studies and external collaborations.* Product Manager, Medical Marketing, Kaletra. Medical advisory program development and management, conference competitive intelligence, and opinion leader development. * Senior Manager, Global New Product Planning. Market research, financial modeling, and forecasting for anti-viral, anti-infective, and pain therapeutic areas. * Manager, Business Development, Abbott Renal. Developed life-cycle management strategy with Zemplar commercial team. Completed due diligence and negotiations for in-licensing of novel injectable iron oligosaccharide. * Manager, Corporate Planning and Development. Developed strategies for Abbott entry into the cardiovascular device marketplace.
Consultant
Developed strategic business solutions for Fortune 500 companies in pharmaceuticals, biotech, energy, telecommunications, and life sciences sectors.
Post-Doctoral Research Fellow
Department of Molecular Genetics and Cell Biology National Science Foundation Post-doctoral Research Fellow
Colleagues at CSL
Other employees you can reach at csl.com.au. View company contacts for 23400 employees →
Sven Brickum
Colleague at CslMarburg An Der Lahn, Hesse, Germany
View →
VC
Varinder Cheema
Colleague at CslLondon, England, United Kingdom
View →
SN
Sash Neskovski
Colleague at CslGreater Melbourne Area, Australia
View →
JB
Julie Boardman
Colleague at CslGreater Sydney Area, Australia
View →
DC
Danielle Christou
Colleague at CslGreater Melbourne Area, Australia
View →
AG
Antonio Gomez
Colleague at CslCorpus Christi, Texas, United States
View →
KB
Kristin B.
Colleague at CslBlue Bell, Pennsylvania, United States
View →
SM
Simon Morris
Colleague at CslYork, England, United Kingdom
View →
JK
Jasmine Kaur
Colleague at CslCaulfield East, Victoria, Australia
View →
DM
Dr. Mario Geist
Colleague at CslWedemark, Lower Saxony, Germany
View →
Michael Fath, Phd education
Doctor Of Philosophy - Phd, Microbiology And Molecular Genetics
Bachelor Of Arts - Ba, Microbiology And Chemistry (Double Major)
Education record
Microbiology And Chemistry (Double Major)
Education record
Frequently asked questions about Michael Fath, Phd
Quick answers generated from the profile data available on this page.
What company does Michael Fath, Phd work for?
Michael Fath, Phd works for CSL.
What is Michael Fath, Phd's role at CSL?
Michael Fath, Phd is listed as Medical Science Liaison at CSL.
Where is Michael Fath, Phd based?
Michael Fath, Phd is based in Chapel Hill, North Carolina, United States while working with CSL.
What companies has Michael Fath, Phd worked for?
Michael Fath, Phd has worked for Csl, Cavabio Consulting Llc, Medsurgpi, Llc, Metabolon, Inc., and Grifols.
Who are Michael Fath, Phd's colleagues at CSL?
Michael Fath, Phd's colleagues at CSL include Sven Brickum, Varinder Cheema, Sash Neskovski, Julie Boardman, and Danielle Christou.
How can I contact Michael Fath, Phd?
You can use AeroLeads to view verified contact signals for Michael Fath, Phd at CSL, including work email, phone, and LinkedIn data when available.
What schools did Michael Fath, Phd attend?
Michael Fath, Phd holds Doctor Of Philosophy - Phd, Microbiology And Molecular Genetics from Harvard University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial